Form 4: VolitionRx Chief Medical Officer Andrew Retter Reports Tax Withholding Transaction
SEC Form 4 Filing
Andrew Retter, Chief Medical Officer of VolitionRx, reports a transaction involving the withholding of shares to cover tax obligations upon the settlement of restricted stock units.
Summary
- On May 1, 2025, Andrew Retter, the Chief Medical Officer of VolitionRx Ltd, had 3,913 common stock shares withheld by the company to cover tax obligations.
- This was due to the settlement of 8,326 restricted stock units awarded in lieu of cash compensation.
- The shares were withheld at a price of $0.4875 per share.
- Following the transaction, Retter directly owns 133,704 shares of VolitionRx common stock.
Sentiment
Score: 5
Explanation: This is a neutral transaction related to tax obligations and doesn't inherently indicate positive or negative sentiment about the company's prospects.
Industry Context
Form 4 filings are a routine part of compliance for company insiders and provide transparency into their transactions in the company's stock. This transaction is related to compensation and tax obligations, which is a common occurrence.
Key Dates
| Date | Description |
|---|---|
| 05/01/2025 | Date of transaction: Shares withheld for tax obligations. |
| 05/05/2025 | Date of signature on the Form 4 filing. |
Keywords
Form 4, Beneficial Ownership, VolitionRx, VRNX, Andrew Retter, Chief Medical Officer, Tax Withholding, Restricted Stock Units
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.